Additional prognostic parameters in patients with myelodysplastic syndromes in the IPSSR intermediate risk group L. H. Lanfermann, K. Nachtkamp,A. Kasprzak, J. Kaivers,B. Hildebrandt, B. Betz,S. Blum, H. -J Schuette, A. Nusch,M. Luebbert, A. Giagounidis, S. Parmentier, D. Haase, N. Gattermann, R. Haas, U. GermingONCOLOGY RESEARCH AND TREATMENT（2021）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
